Share the Science: Drs. Malhotra & Zhou - Potential Cord Blood Cell Therapy for Preterm Brain Injury

​Save the Cord Foundation and WellSky are proud to welcome Dr. Atul Malhotra and Dr. Lindsay Zhou as our featured speakers for the next edition of Share the Science on Wednesday, August 17th, 2022 at 5pm US Eastern Time / 4pm US Central Time. Join us to hear Dr. Malhotra and Dr. Zhou discuss their research on the potential use of cord blood in cell therapy to treat brain injury in preterm infants.

RECORDING NOW AVAILABLE (watch via the Share the Science archive)

​Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.

Cell Therapy for Brain Injury:
​What does the future hold?

Brain injury continues to be a severe complication as a result of of preterm birth.  In response, prevention and treatment of brain injury in neonates remains a key area of interest for researchers exploring the potential of umbilical cord blood and cord blood-derived cell therapies. In particular, umbilical cord blood-derived cells are being continuously evaluated for their neuroprotective and neuroreparative properties in preclinical and clinical studies. Numerous clinical trials have suggested that cord blood has the potential to reduce apoptosis, inflammatory cytokines and oxidative stress in the brain.

For this edition of Share the Science, we are pleased to welcome both Dr. Atul Malhotra and Dr. Lindsay Zhou from Monash University who will discuss the potential of cord blood in the treatment of brain injury. In particular, they will discuss their own research in this area and a study to test the feasibility of collection and isolation of sufficient UCBCs from cord blood, and the safety of intravenous administration of autologous UCBCs in extremely preterm infants suffering from brain injury during the neonatal period. 

Join us for this fascinating discussion with Dr. Atul Malhotra and Dr. Lindsay Zhou. 
​

SHARE THE SCIENCE
with
Dr. Atul Malhotra & Dr. Lindsay Zhou
Monash Children's Hospital, Department of Paediatrics,
Monash University - Melbourn, Australia
 
"Autologous Umbilical Cord Blood-Derived Cell
Administration in Extreme Preterm Infants" 
Free webinar.  Open to the public.
​
Wednesday, August 17th, 2022  5pm US Eastern Time / 4pm US Central Time
​

RECORDING NOW AVAILABLE
via the Share the Science Archive

Watch NOW via Share the Science Archive:  Cord Blood Cell Therapy for Preterm Brain Injury

About the speakers

Dr. Atul Malhotra
​
Senior Consultant Neonatologist and Head of the Early Neurodevelopment Clinic at Monash Children's Hospital and Associate Professor (Research) & NHMRC Fellow in the Department of Paediatrics, Monash University.

Associate Professor Atul Malhotra is a Senior Consultant Neonatologist and Head of the Early Neurodevelopment Clinic at Monash Children's Hospital and Associate Professor (Research) & NHMRC Fellow in the Department of Paediatrics, Monash University. He has published over 120 peer-reviewed journal articles, 4 book chapters and his research has attracted over $7.5 million of funding to date. He is also the co-Director of the Newborn Cell Therapies Group at Monash, which has been instrumental in the translation of preclinical therapies from the laboratory to the clinic, including regenerative cell therapies. He led a world-first trial of placental amnion epithelial cells for chronic lung disease of prematurity, and is the Principal Investigator of two cord blood derived cell therapy trials currently recruiting.

---

Dr. Lindsay Zhou
​
Consultant Neonatologist at Monash Children's Hospital and a PhD student at the Ritchie Centre and Department of Paediatrics, Monash University.

Dr Lindsay Zhou is a Consultant Neonatologist at Monash Children's Hospital and a PhD student at the Ritchie Centre and Department of Paediatrics, Monash University. Dr. Zhou undertook his paediatric and neonatal training in Melbourne, and also works as a Retrieval Consultant at the Royal Children's Hospital Melbourne. His PhD studies focus on umbilical cord-blood derived cell therapy applications for extremely preterm infants. He is an Associate Investigator on the CordSaFe clinical trial, investigating the safety and feasibility of umbilical cord blood-derived cell collection and administration in infants born at less than 28 weeks.

---

We wish to thank Dr. Atul Malhotra & Dr. Lindsay Zhou for volunteering their time to speak on
Share the Science and sharing their valuable insight
on the potential of using cord blood in cell therapy to treat preterm brain injury in enfants.
​​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.